| dmelAC |
2 environments × 16 strains × 2 sexes |
17860 |
367 |
7 |
ERCC 78A, centrifuge |
| dmelAV |
2 environments × 16 strains × 2 sexes |
17860 |
165 |
15 |
ERCC 78A, vacuum |
| mpreg1a |
3 brain regions × 3 post-partum stages |
55493 |
27 |
14 |
ERCC, 1:10 dilution |
| mpreg1b |
1 brain region × 3 post-partum stages |
55493 |
9 |
15 |
ERCC, 1:100 dilution |
| mpreg2a |
3 brain regions × 3 stages |
55493 |
27 |
16 |
ERCC, 1:10 dilution |
| mpreg2b |
1 brain region × 3 stages |
55493 |
9 |
17 |
ERCC, 1:100 dilution |
| rbm1 |
5 organs × 4 stages × 2 sexes |
32975 |
159 |
28 |
ERCC Mix 1 |
| rbm2 |
6 organs × 4 stages × 2 sexes |
32975 |
159 |
27 |
ERCC Mix 2 |
| rnor1 |
26 chemicals |
32975 |
64 |
37 |
ERCC Mix 1 |
| rnor2 |
16 chemicals |
32975 |
52 |
37 |
ERCC Mix 2 |
| sarcoma |
9 diseases × 2 metastatic states |
58380 |
125 |
36 |
ERCC Mix, Life Technologies |
| lymphoma |
4 cell lines × 3 treatments |
58380 |
34 |
11 |
ERCC Mix 1, 1 µL to 5000 ng RNA |
| yfv |
2 cell models × 3 infections |
58380 |
24 |
21 |
ERCC Mix 1 |
| xtro1m |
Time series, replicated in 2 clutches |
21550 |
145 |
16 |
ERCC Mix 1, polyA enrichment |
| xtro2 |
Time series |
21550 |
48 |
28 |
ERCC Mix 1, RiboZero enrichment |